TY - JOUR
T1 - Proteins in the pathway from high red blood cell width distribution to all-cause mortality
AU - Osawa, Yusuke
AU - Tanaka, Toshiko
AU - Semba, Richard D.
AU - Fantoni, Giovanna
AU - Moaddel, Ruin
AU - Candia, Julián
AU - Simonsick, Eleanor M.
AU - Bandinelli, Stefania
AU - Ferrucci, Luigi
N1 - Funding Information:
This study was funded by grants from the National Institutes of Health (R01AG027012, R01AG057723, R01HL111271, and R21HL112662) and National Institute on Aging contract 263MD9164 and was supported by the Intramural Research Program of the National Institute on Aging, National Institutes of Health. The InCHIANTI study baseline (1998–2000) was supported as a ‘targeted project' ICS110.1/RF97.71) by the Italian Ministry of Health and in part by the U.S. National Institute on Aging (Contracts: 263 MD 9164 and 263 MD 821,336); the InCHIANTI Follow-up 1 (2001–2003) was funded by the U.S. National Institute on Aging (Contracts: N.1-AG-1–1 and N.1-AG-1–2111); and the InCHIANTI Follow-ups 2 and 3 studies (2004–2010) were financed by the U.S. National Institute on Aging (Contract: N01-AG-5–0002) and supported in part by the Intramural Research Program of the National Institute on Aging, National Institutes of Health, Baltimore, Maryland. The funders were not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.
Funding Information:
This study was funded by grants from the National Institutes of Health (R01AG027012 and R01AG057723 to Dr. Semba, and R01HL111271 and R21HL112662 to Dr. Ferrucci) and National Institute on Aging contract 263MD9164 (to Dr. Ferrucci) and was supported by the Intramural Research Program of the National Institute on Aging, National Institutes of Health. The InCHIANTI study baseline (1998–2000) was supported as a ‘targeted project' ICS110.1/RF97.71) by the Italian Ministry of Health and in part by the U.S. National Institute on Aging (Contracts: 263 MD 9164 and 263 MD 821336); the InCHIANTI Follow-up 1 (2001–2003) was funded by the U.S. National Institute on Aging (Contracts: N.1-AG-1–1 and N.1-AG-1–2111); and the InCHIANTI Follow-ups 2 and 3 studies (2004–2010) were financed by the U.S. National Institute on Aging (Contract: N01-AG-5–0002) and supported in part by the Intramural Research Program of the National Institute on Aging, National Institutes of Health, Baltimore, Maryland.
Publisher Copyright:
© 2022
PY - 2022/2
Y1 - 2022/2
N2 - Background: The pathophysiological mechanisms underlying the association between red blood cell distribution width (RDW) and all-cause mortality are unknown. We conducted a data-driven discovery investigation to identify plasma proteins that mediate the association between RDW and time to death in community-dwelling adults. Methods: At baseline, 962 adults (women, 54·4%; age range, 21–98 years) participated in the InCHIANTI, “Aging in the Chianti Area” study, and proteomics data were generated from their plasma specimens. Of these, 623 participants had proteomics data available at the 9-year follow-up. For each visit, a total of 1301 plasma proteins were measured using SOMAscan technology. Complete data on vital status were available up to the 15-year follow-up period. Protein-specific exponential distribution accelerated failure time, and linear regression analyses adjusted for possible covariates were used for mortality and mediation analyses, respectively (survival data analysis). Findings: Baseline values of EGFR, GHR, NTRK3, SOD2, KLRF1, THBS2, TIMP1, IGFBP2, C9, APOB, and LRP1B mediated the association between baseline RDW and all-cause mortality. Changes in IGFBP2 and C7 over 9 years mediated the association between changes in RDW and 6-year all-cause mortality. Interpretation: Cellular senescence may contribute to the association between RDW and mortality. Funding: This study was funded by grants from the National Institutes of Health (NIH) and the National Institute on Aging (NIA) contract and was supported by the Intramural Research Program of the NIA, NIH. The InCHIANTI study was supported as a ‘targeted project’ by the Italian Ministry of Health and in part by the U.S. NIA.
AB - Background: The pathophysiological mechanisms underlying the association between red blood cell distribution width (RDW) and all-cause mortality are unknown. We conducted a data-driven discovery investigation to identify plasma proteins that mediate the association between RDW and time to death in community-dwelling adults. Methods: At baseline, 962 adults (women, 54·4%; age range, 21–98 years) participated in the InCHIANTI, “Aging in the Chianti Area” study, and proteomics data were generated from their plasma specimens. Of these, 623 participants had proteomics data available at the 9-year follow-up. For each visit, a total of 1301 plasma proteins were measured using SOMAscan technology. Complete data on vital status were available up to the 15-year follow-up period. Protein-specific exponential distribution accelerated failure time, and linear regression analyses adjusted for possible covariates were used for mortality and mediation analyses, respectively (survival data analysis). Findings: Baseline values of EGFR, GHR, NTRK3, SOD2, KLRF1, THBS2, TIMP1, IGFBP2, C9, APOB, and LRP1B mediated the association between baseline RDW and all-cause mortality. Changes in IGFBP2 and C7 over 9 years mediated the association between changes in RDW and 6-year all-cause mortality. Interpretation: Cellular senescence may contribute to the association between RDW and mortality. Funding: This study was funded by grants from the National Institutes of Health (NIH) and the National Institute on Aging (NIA) contract and was supported by the Intramural Research Program of the NIA, NIH. The InCHIANTI study was supported as a ‘targeted project’ by the Italian Ministry of Health and in part by the U.S. NIA.
KW - Aging
KW - Insulin-like growth factor-binding protein 2
KW - Mortality
KW - Proteomics
KW - Red blood cell distribution width
UR - http://www.scopus.com/inward/record.url?scp=85123126747&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85123126747&partnerID=8YFLogxK
U2 - 10.1016/j.ebiom.2022.103816
DO - 10.1016/j.ebiom.2022.103816
M3 - Article
C2 - 35065420
AN - SCOPUS:85123126747
SN - 2352-3964
VL - 76
JO - EBioMedicine
JF - EBioMedicine
M1 - 103816
ER -